MB-201(Must Bio)

N/A

Report date: 2025/12/05 17:00:18

Base Information

Drug NameMB-201(Must Bio)

Drug Alias NameMB-201MB201

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionAntibody-dependent cell-mediated cytotoxicity (ADCC) effectsAnti-Programmed death-ligand 1T lymphocytes stimulants +[4]

TargetsProgrammed death-ligand 1Interleukin-2 receptor

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesMUSTBIO Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesMUSTBIO Co Ltd

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A